Number of circulating endothelial progenitor cells as a marker of vascular endothelial function for type 2 diabetes

Vascular Medicine

Volumn 15, Issue 4, 2010, Pages 279-285

  Liao, Yun Fei ^a   Chen, Lu Lu ^a   Zeng, Tian Shu ^a   Li, Yu Ming ^a   Yu, Fan ^a   Hu, Li Jun ^a   Yue, Ling ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

Author keywords

Endothelial function; Endothelial progenitor cell; Flow mediated dilatation; Type 2 diabetes

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN; METFORMIN; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; ENDOTHELIUM CELL; FEMALE; FLOW MEASUREMENT; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; STEM CELL; VASCULAR ENDOTHELIUM;

ADULT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED;

EID: 77955905039     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X10367537     Document Type: Article

References (27)

1. Creager MA, Lüscher TF, Cosentino F., et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 2003 ; 108: 1527-1532.
2. Tooke JE, Goh KL Vascular function in type 2 diabetes mellitus and pre-diabetes: the case for intrinsic endotheiopathy. Diabet Med 1999 ; 16: 710-715.
3. Grover-Páez F., Zavalza-Gómez AB Endothelial dysfunction and cardiovascular risk factors. Diabetes Res Clin Pract 2009 ; 84: 1-10.
4. Cohn JN, Quyyumi AA, Hollenberg NK, et al. Surrogate markers for cardiovascular disease: functional markers. Circulation 2004 ; 109: 31-46.
5. Rafii S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003 ; 9: 702-712.
6. Rosenzweig A. Circulating endothelial progenitors - cells as biomarkers. N Engl J Med 2005 ; 353: 1055-1057.
7. Fadini GP, Sartore S., Baesso I., et al. Endothelial progenitor cells and the diabetic paradox. Diabetes Care 2006 ; 29: 714-716.
8. Fadini GP, Sartore S., Albiero M., et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 2006 ; 26: 2140-2146.
9. Tepper OM, Galiano RD, Capla JM, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002 ; 106: 2781-2786.
10. Fadini GP, Agostini C., Avogaro A. Endothelial progenitor cells and vascular biology in diabetes mellitus: current knowledge and future perspectives. Curr Diabetes Rev 2005 ; 1: 41-58.
11. Werner N., Wassmann S., Ahlers P., et al. Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease. Basic Res Cardiol 2007 ; 102: 565-571.
12. Wang CH, Ting MK, Verma S., et al. Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance. Diabetes Care 2006 ; 29: 1083-1089.
13. Davis BJ, Xie Z., Viollet B., et al. Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes 2006 ; 55: 496-505.
14. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998 ; 352: 854-865.
15. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997 ; 20: 1183-1197.
16. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005 ; 353: 999-1007.
17. Kim W., Jeong MH, Cho SH, et al. Effect of green tea consumption on endothelial function and circulating endothelial progenitor cells in chronic smokers. Circ J 2006 ; 70: 1052-1057.
18. Xiang GD, Xu L., Zhao LS, et al. The relationship between plasma osteoprotegerin and endothelium-dependent arterial dilation in type 2 diabetes. Diabetes 2006 ; 55: 2126-2131.
19. Avogaro A., Toffolo G., Kiwanuka E., et al. L-arginine-nitric oxide kinetics in normal and type 2 diabetic subjects: a stable-labelled 15N arginine approach. Diabetes 2003 ; 52: 795-802.
20. Verma S., Anderson TJ Fundamentals of endothelial function for the clinical cardiologist. Circulation 2002 ; 105: 546-549.
21. Thum T., Bauersachs J. Spotlight on endothelial progenitor cell inhibitors: short review. Vasc Med 2005 ; 10 (suppl 1). S59-64.
22. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001 ; 89: E1 - E7.
23. Schmidt-Lucke C., Rossig L., Fichtlscherer S., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005 ; 111: 2981-2987.
24. Hill JM, Zalos G., Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003 ; 348: 593-600.
25. Thum T., Fraccarollo D., Schultheiss M., et al. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 2007 ; 56: 666-674.
26. Wang CH, Ciliberti N., Li SH, et al. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy. Circulation 2004 ; 109: 1392-1400.
27. Imanishi T., Hano T., Nishio I. Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells. Hypertens Res 2004 ; 27: 101-108.